World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
9265
World Ranking
15746
National Ranking
6559

Li Yan publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Li Yan sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 243 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Li Yan D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Li Yan sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Li Yan is affiliated with the Roswell Park Comprehensive Cancer Center in the United States. Their research primarily focuses on oncology and molecular biology, with extensive work in cancer research and immunology. The main fields of study associated with their work include Medicine and Biochemistry, Genetics and Molecular Biology.

Yan has published numerous papers, notably in journals such as Cancers, Journal of Clinical Oncology, Cancer Research, Scientific Reports, and International Journal of Molecular Sciences. Their publications cover a wide range of topics related to cancer immunotherapy and biomarkers, ferroptosis and cancer prognosis, cancer genomics and diagnostics, immune cells in cancer, immunotherapy and immune responses, epigenetics and DNA methylation, and cancer-related molecular mechanisms research.

Some recent key papers authored by Yan include:

  • "M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer" (2020, Scientific Reports)
  • "CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer" (2020, International Journal of Molecular Sciences)
  • "G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer" (2020, International Journal of Molecular Sciences)
  • "The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer" (2020, Cells)
  • "Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer" (2020, Cancers)

Yan frequently collaborates with a core group of coauthors contributing to cancer research, including Kazuaki Takabe, Masanori Oshi, Yoshihisa Tokumaru, Itaru Endo, and Ryusei Matsuyama. These collaborations have resulted in multiple publications advancing the understanding of cancer biology and treatment.

The publication venues where Yan has contributed the most include:

  • Cancers (19 publications)
  • Journal of Clinical Oncology (10 publications)
  • Cancer Research (7 publications)
  • Scientific Reports (6 publications)
  • International Journal of Molecular Sciences (6 publications)

Yan's work has a strong emphasis on identifying and validating biomarkers for cancer prognosis and treatment response, particularly in breast cancer subtypes. Their focus on immune cells, pathway scores, and molecular mechanisms reflects an interdisciplinary approach combining clinical oncology with molecular and cellular biology.

Best Publications

  • The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL) MODULATION OF MMP-9 ACTIVITY BY NGAL

    Li Yan;Niels Borregaard;Lars Kjeldsen;Marsha A. Moses

  • The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer Patients

    Cecilia A. Fernández;Li Yan;Gwendolyn Louis;Jiang Yang

  • IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data.

    Dan Wang;L i Yan;Qiang Hu;Lara E. Sucheston

  • Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.

    Eric E. Gabison;Samia Mourah;Emanuelle Steinfels;Li Yan

  • Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients

    Kerry-Ann McDonald;Tsutomu Kawaguchi;Tsutomu Kawaguchi;Qianya Qi;Xuan Peng

  • CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.

    Masanori Oshi;Masanori Oshi;Mariko Asaoka;Mariko Asaoka;Yoshihisa Tokumaru;Yoshihisa Tokumaru;Li Yan

  • M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer.

    Masanori Oshi;Masanori Oshi;Yoshihisa Tokumaru;Yoshihisa Tokumaru;Mariko Asaoka;Mariko Asaoka;Li Yan

  • G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer

    Masanori Oshi;Masanori Oshi;Hideo Takahashi;Yoshihisa Tokumaru;Yoshihisa Tokumaru;Li Yan

  • Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.

    Sumana Narayanan;Tsutomu Kawaguchi;Li Yan;Xuan Peng

  • Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.

    Maiko Okano;Masanori Oshi;Ali Linsk Butash;Eriko Katsuta

  • Pancreatic adenocarcinomas with mature blood vessels have better overall survival.

    Eriko Katsuta;Qianya Qi;Xuan Peng;Steven N. Hochwald;Steven N. Hochwald

  • The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2- Breast Cancer.

    Masanori Oshi;Masanori Oshi;Hideo Takahashi;Yoshihisa Tokumaru;Yoshihisa Tokumaru;Li Yan

  • Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).

    Sara Y Kim;Tsutomu Kawaguchi;Li Yan;Jessica Young

  • KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.

    Yoshihisa Tokumaru;Yoshihisa Tokumaru;Masanori Oshi;Eriko Katsuta;Li Yan

  • Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer.

    Sumana Narayanan;Tsutomu Kawaguchi;Xuan Peng;Qianya Qi

  • Circulating miR-148b and miR-133a as biomarkers for breast cancer detection

    Jie Shen;Qiang Hu;Michael Schrauder;Li Yan

  • Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

    Masanori Oshi;Mariko Asaoka;Mariko Asaoka;Yoshihisa Tokumaru;Yoshihisa Tokumaru;Fernando A. Angarita

  • Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.

    Kazuki Moro;Tsutomu Kawaguchi;Junko Tsuchida;Emmanuel Gabriel

  • Adolescent smoking in Wuhan, China: Baseline data from the Wuhan smoking prevention trial

    Jennifer B Unger;Li Yan;Xinguang Chen;Xia Jiang

  • Plasma Metabolomic Profiles in Breast Cancer Patients and Healthy Controls: By Race and Tumor Receptor Subtypes

    Jie Shen;Li Yan;Song Liu;Christine B. Ambrosone

Frequent Co-Authors

Kazuaki Takabe
Kazuaki Takabe Roswell Park Cancer Institute
Itaru Endo
Itaru Endo Yokohama City University
Stephen R. Spellman
Stephen R. Spellman Medical College of Wisconsin
Daniel O. Stram
Daniel O. Stram University of Southern California
Christine B. Ambrosone
Christine B. Ambrosone Roswell Park Cancer Institute
Christopher A. Haiman
Christopher A. Haiman University of Southern California
David Van Den Berg
David Van Den Berg University of Southern California
Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Carl Morrison
Carl Morrison Roswell Park Cancer Institute
Candace S. Johnson
Candace S. Johnson Roswell Park Cancer Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens up a wealth of online educational and career pathways. For students eager to fast-track their education, an accelerated biology degree offers an intensive curriculum that can help you graduate faster, supporting a quicker entry into healthcare, research, or biotech roles.

Many professionals begin their careers as medical assistants. For those wishing to advance, there are ma to lpn bridge programs online. These programs allow medical assistants to become Licensed Practical Nurses (LPNs) efficiently, often while balancing work and family commitments.

Pursuing an asn online is another popular choice. This flexible pathway allows you to earn an Associate of Science in Nursing remotely, helping you access in-demand healthcare careers and laying the foundation for advanced nursing roles.

Lastly, if you are interested in food science or public health, an online nutrition degree can lead to roles in clinical nutrition, research, education, or wellness industries. Each of these online pathways offers unique advantages and career advancement opportunities for those passionate about biology, biochemistry, and healthcare.

Best Scientists Citing Li Yan

Trending Scientists

Recently Published Articles